beta

DXR

Daxor Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

the bva-100 (blood volume analyzer) is the first instrument of its kind that can precisely measure the amount of blood a patient has in their body. blood volume measurements have been available for almost 60 years, but the test often took 4 to 8 hours to perform and was very difficult to perform accurately. due to these issues, blood volume measurements were very rarely done. physicians had been forced to rely on substitute tests that were only able to measure the thickness of the blood and can be very misleading in many surgical and medical situations. the bva-100 can measure blood volume: accurately, quickly & reliably.

Market Cap: 35.5 Million

Primary Exchange: NASDAQ

Website: daxor.com

Shares Outstanding: 4.73 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.0

Sector: Manufacturing

Industry: Surgical and Medical Instrument Manufacturing

Ethical Flags

Longest drawdown: 1169 trading days

From: 2020-07-17 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2018-01-05 2018-01-12 2018-01-08 2017-12-28 0.03 No Change QoQ
2016-12-20 2016-12-29 2016-12-22 2016-11-18 0.03 Decrease
2015-12-18 2015-12-29 2015-12-22 2015-12-10 0.04 Increase
2014-12-04 2014-12-26 2014-12-08 2014-11-17 0.03 Decrease
2018-01-05 2018-01-12 2018-01-08 2017-12-21 0.029999999329447746 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud